Physician profile
Rami Y Eid
NPI 1144217050
$4,738.48
in general payments reported to CMS, 2019-2025
20 companies · $1,163 in 2025
The $1,163 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $249 · 2020: $109 · 2021: $603 · 2022: $856 · 2023: $731 · 2024: $1,027 · 2025: $1,163.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,922.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,921.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,991.10 | 2019-2025 | |
| Pfizer INC. | $404.06 | 2019-2025 | |
| Celgene Corporation | $211.15 | 2021-2024 | Zeposia |
| Qol Medical, LLC | $197.98 | 2023-2025 | Sucraid, Sucraid |
| Conmed Corporation | $165.69 | 2024 | Conmed Biliary |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $163.31 | 2019-2022 | |
| Genzyme Corporation | $106.99 | 2022-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $105.89 | 2019-2025 | Eohilia |
| Janssen Biotech, INC. | $77.89 | 2022-2025 | Tremfya |
| Phathom Pharmaceuticals, INC. | $63.87 | 2024-2025 | Voquezna |
| Ardelyx, INC. | $34.90 | 2022-2025 | Ibsrela |
| Braintree Laboratories, INC. | $33.13 | 2021-2023 | Suflave |
| Merck Sharp & Dohme LLC | $29.53 | 2024 | Dificid |
| Regeneron Healthcare Solutions, INC. | $29.12 | 2025 | Dupixent |
| Ironwood Pharmaceuticals, INC | $27.34 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $26.99 | 2021-2024 | |
| Apollo Endosurgery US INC | $20.31 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $18.24 | 2022 | |
| Intra-Sana Laboratories | $16.07 | 2022 | |
| Nestle Healthcare Nutrition INC. | $14.92 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rami Eid listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.